期刊文献+

血管内皮生长因子及其受体与白血病的关系

Relationship between VEGF and its receptors in leukemia patients
原文传递
导出
摘要 血管内皮生长因子(vascular endothelial growth factor,VEGF)是作用最强,特异性最高的血管新生调节因子,研究表明,白血病细胞不仅高表达VEGF,而且不同程度的表达VEGF受体,VEGF与白血病的发生、发展相关,影响白血病的预后。研究VEGF与白血病的关系,为白血病的抗血管增生治疗提供依据。 Vascular endothelia growth factor (VEGF) and its receptors (VEGFR) have been implicated in promoting solid tumor growth and metastasis via stimulating tumor-associated angiogenesis. Recently, studies showed that angiogenesis may also play an important role in the growth of leukemia. Leukemia not only produce VEGF, but also express functional VEGFR. Serum VEGF levels have prognostic significance in patients with leukemia. This review summarize the relationship between VEGF ,VEGFR and leukemia.
出处 《白血病.淋巴瘤》 CAS 2006年第1期71-74,共4页 Journal of Leukemia & Lymphoma
关键词 白血病 抗血管增生治疗 血管内皮生长因子 Leukemia Vascular endothelia growth factor Angiogenesis
  • 相关文献

参考文献33

  • 1Keyhani A,Jendiroba D B,reireich E J.Angiogenesis and leukemia[J].Leuk Res,2001,25(8):639-645.
  • 2Brekken R A,Overholser J P,Stastny V A,et al.Selective inhibition of vascular endothelial growth factor(VEGF) receptor 2 (KDR/Flt-1)activity by a monoclonal antibody blocks tumor growth in mice [J].Cancer Res,2000,60(18):5117-5124.
  • 3Bellamy W T,Richter L,Sirjani D,et al.Vascular endothelial growth factors is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes[J].Blood,2001,97(5):1427-1434.
  • 4Dias S,Hattori K,Heissig B,et al.Inhibition of both paracrine and autocrine VEGF/VEGFR2-signaling pathways is essential to induce longterm remission of xenotransplanted human leukemias[J].Proc Natl Acad Sci U S A,2001,98(19):10857-10862.
  • 5Dias S,Hattori K,Zhu Z P,et al.Antocrine stimulation of VEGF-2acvitvates human leukemia cell growth and migration [J].J Clin Invest,2000,106(4):2532-2546.
  • 6Ferrajoli A,Manshouri T,Estrov Z,et al.High levels of vascular endothelial growth factor receptor-2 correlate with shortened survival in chronic lymphocytic leukemia[J].Clin Cancer Res,2001,7(4):795.
  • 7谢建民,齐振华.急性白血病VEGF及受体KDR的表达与其侵袭关系研究[J].中华血液学杂志,2004,25(7):435-436. 被引量:3
  • 8Aguayo A,Manshoui T,Brien S,et al.Clinical relevance of Flt1 and Tie angiogenesis receptors espression in B-cell chronic lymphocytic leukemia (CLL)[J].Leu Res,2001,25(4):279.
  • 9Bellamy W T,Richter L,Frutiger Y,et al.Expression of vascular en2dothelial growth factor and its receptors in hernatopoietic malignancies[J].Cancer Res,1999,59(3):728-733.
  • 10张伶,陈辉,李维,涂植光,冯文莉,黄宗干.血管内皮生长因子及其Flt-1受体在白血病细胞中的表达[J].第三军医大学学报,2004,26(8):678-681. 被引量:8

二级参考文献43

  • 1Aguayo A, Kantarjian H, Manshoori T, et al. Angiagenesis in acute and chronic leukemias and myeledysplastic syndromes[J]. 2Blood, 2000, 96(6): 2240 - 2245.
  • 2Chen H, Treweeke A T, West D C, et al. In vitro and in vivo production of vascular endothelial growth factor by chronic lymphocytic leukemia cells[J]. 2Blood, 2000, 96 (9): 3181 -3187.
  • 3Dias S, Hattori K, Zhu Z P, et al. Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration[J]. J Clin Invest, 2000,106(4): 511-521.
  • 4Aguayo A, Manshouri T, O' Brien S, et cd. Clinical relevance of Fltl and Tiel angiogenesis receptors expression in B-cell chronic lymphocytic leukemia (CLL)[J]. Leuk Res, 2001, 25(4): 279-285.
  • 5Fiedler W, Graeven U, Ergun S, et cd. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia[J]. Blood, 1997, 89(6): 1870-1875.
  • 6Bellamy W T, Richter L, Frutiger Y, et al. Expression of vascular endothelial cell growth factor and its receptors in hematopoietic malignancies[ J].Cancer Res, 1999, 59(3): 728 - 733.
  • 7Fusetti L, Pruneri G, Cobbi A, et cd. Human myeloid and lymphoid malignancies in the non-obese diabetic/severe combined immunodeficiency mouse model: frequence of apoptotic cells in solid tumors and efficiency and speed of engraftment correlate with vascu
  • 8Broggini M, Marchini S V, Galliera E, et al. Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF)secretion and blocks VEGF-VEGFR-I (fit-l) antocrine loop in human leukemia cells MOLT-4[J]. Leukemia, 2003, 1
  • 9Oyama T, Ran S, Ishida T, Nadaf S, et cd. Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells [ J ]. J Immunol,1998, 160(3): 1224-1232.
  • 10Saiki, Murata J, Watanabe K, et al. Inhibition of tumor cell invasion by ubenimex in vitro. Jpn J Cancer Res, 1989, 80: 873-878.

共引文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部